Versant Capital Management’s Medifast MED Stock Holding History

Versant Capital Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.29K	Buy	310 +51	+20%	+$588	﹤0.01%	2505
2026 Q1	$2.64K	Sell	259 -1,130	-81%	-$12.2K	﹤0.01%	2519
2025 Q4	$14.8K	Sell	1,389 -29	-2%	-$347	﹤0.01%	1814
2025 Q3	$19.4K	Sell	1,418 -233	-14%	-$3.25K	﹤0.01%	1598
2025 Q2	$23.2K	Buy	1,651 +1,029	+165%	+$13.5K	﹤0.01%	1439
2025 Q1	$8.38K	Buy	622 +90	+17%	+$1.35K	﹤0.01%	1806
2024 Q4	$9.37K	Buy	+532	New	+$9.87K	﹤0.01%	1435
2024 Q2	–	Sell	-23	Closed	-$881	–	1981
2024 Q1	$881	Buy	23 +20	+667%	+$969	﹤0.01%	1571
2023 Q4	$202	Sell	3 -6	-67%	-$418	﹤0.01%	1865
2023 Q3	$674	Sell	9 -23	-72%	-$2.04K	﹤0.01%	1643
2023 Q2	$2.95K	Buy	32 +22	+220%	+$1.96K	﹤0.01%	1228
2023 Q1	$1.04K	Buy	+10	New	+$1.11K	﹤0.01%	1431
2019 Q2	–	Sell	-11	Closed	-$1K	–	1586
2019 Q1	$1K	Hold	11	–	–	﹤0.01%	1458
2018 Q4	$1K	Sell	11 -8	-42%	-$1.37K	﹤0.01%	1373
2018 Q3	$4K	Hold	19	–	–	﹤0.01%	1154
2018 Q2	$3K	Hold	19	–	–	﹤0.01%	1218
2018 Q1	$1K	Hold	19	–	–	﹤0.01%	1388
2017 Q4	$1K	Hold	19	–	–	﹤0.01%	1433
2017 Q3	$1K	Sell	19 -28	-60%	-$1.39K	﹤0.01%	1351
2017 Q2	$1K	Hold	47	–	–	﹤0.01%	1347
2017 Q1	$2K	Hold	47	–	–	﹤0.01%	1239
2016 Q4	$1K	Hold	47	–	–	﹤0.01%	1303
2016 Q3	$1K	Hold	47	–	–	﹤0.01%	1290
2016 Q2	$1K	Buy	+47	New	+$1.52K	﹤0.01%	1259
2016 Q1	–	Sell	-193	Closed	-$5K	–	1397
2015 Q4	$5K	Buy	+193	New	+$5.75K	﹤0.01%	939

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Versant Capital Management's MED Position: Q2 2026 in Review

Versant Capital Management increased its Medifast (MED) stake by 20% in Q2 2026, buying an estimated $588 and bringing the position to 310 shares worth $3.29K. The position accounts for ﹤0.01% of the portfolio, ranked #2505.

Versant Capital Management first reported a position in MED in Q4 2015 and has held it in 25 quarters since. The position peaked at $23.2K in Q2 2025. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Versant Capital Management held 310 shares of Medifast worth $3.29K as of Q2 2026.
Versant Capital Management bought 51 Medifast shares in Q2 2026, an estimated $588.
Medifast made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2505 holding.
Versant Capital Management first reported a position in Medifast in Q4 2015 and has held it in 25 quarters since.
Versant Capital Management's Medifast position peaked at $23.2K in Q2 2025.
113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.